MHRA appoints new chair

Professor Anthony Harnden, of Nuffield Department of Primary Care Health Sciences and University of Oxford, has been appointed chair of the Medicines and Healthcare products Regulatory Agency (MHRA).

© University of Oxford

© University of Oxford

He is a professor of Primary Care in the Nuffield Department of Primary Care Health Sciences at the University of Oxford, having first joined the department in 1992. Until the end of December 2024, he is a registrant council member of the General Medical Council and chair of the Renumeraton Committee.

Prof Harnden was a general practitioner for 33 years in Wheatley, Oxfordshire and worked for the NHS for 40 years. He was also previously deputy chair of the Joint Committee on Vaccination and Immunisation and played a key role in ensuring public trust and patient safety during the distribution of the Covid vaccine.

In his new role, Prof Harnden will play a key role in driving forward the strategic direction of MHRA to maintain the UK as a global centre of excellence in life sciences, in the best interests of patients and the public.

Dr June Raine, MHRA chief executive, said: 'Anthony brings with him a wealth of experience from across the healthcare sector and academia that will be invaluable when advising on the strategic direction of the Agency to protect and promote public health.

'I would also like to say an enormous thank you to Amanda Calvert, Michael Whitehouse OBE and Professor Graham Cooke for their sterling work co-chairing the MHRA board on an interim basis since July 2023.'

Prof Harnden said: 'I am looking forward to making a contribution to the future successes of the organisation.

'I will use my experience in healthcare and regulation to help the MHRA deliver its strategic priorities – keeping patients safe and enabling timely access to new medicines and technologies.'

Prof Harnden succeeds former MHRA chair Stephen Lightfoot, who served from September 2020 and stepped down in 2023.

BMA launches legal action against Government over GMC's right to appeal

BMA launches legal action against Government over GMC's right to appeal

By Lee Peart 16 June 2026

Legal action has been launched by the BMA against the Government over its consultation proposing to allow the GMC to retain its right of appeal against decis...

Young people to be offered MenB vaccine following spike in cases

By Lee Peart 12 June 2026

Thousands of young people are to be offered a one-off MenB vaccination this autumn following a spike in cases this year.

NHS Confed Expo: Is the US drug deal good or bad for the NHS?

By Lee Peart 11 June 2026

Leaders debated the merits of the US drug deal during a roundtable panel at NHS Confed Expo yesterday.


Popular articles by Liz Wells